Wed, Mar 24, 2021
Healthcare Services Sector Update – Early Spring 2021
The S&P Healthcare Services Index decreased by 4.5% over the last month, compared to the S&P 500 Index, which increased 1.0% over the same period.
Over the past month:
- The sectors that experienced the most growth were Assisted/Independent Living (up 15.2%), Contract Research Organizations (up 6.6%) and Healthcare REITS (up 5.5%).
- The sectors that experienced the largest decline were Telemedicine (down 18.0%), Dialysis Services (down 15.7%) and Home Medical Equipment/Durable Equipment (down 10.6%).
- The current average Last Twelve Months (LTM) revenue and LTM EBITDA multiples for the healthcare services industry overall are 1.93x and 10.0x, respectively.
The sectors with the highest valuation multiples include:
- Consumer Directed Health/Wellness (4.50x LTM revenue, 27.2x LTM EBITDA)
- HCIT (4.97x LTM revenue, 25.2x LTM EBITDA)
- Home Health/Hospice (2.90x LTM revenue, 24.7x LTM EBITDA)
- Contract Research Organizations (3.72x LTM revenue, 22.4x LTM EBITDA)
Corporate Finance and Restructuring
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions.
Fairness and Solvency Opinions
Duff & Phelps Opinions is a global leader in Fairness Opinions and Special Committee Advisory, ranking #1 for total number of U.S. and global fairness opinions over the past 10 years, according to Refinitiv cumulative data from 2013-2022.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.
Private Capital Markets – Debt Advisory
Kroll has extensive experience raising capital for middle-market companies to support a wide range of transactions.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.